1100022I SRI international; to X9 obra--1 optimization phase in vitro admet and small animal PK studies; biod can 8470038; $737,296
Ended Awarded Last action
- Contract number
- HHSN27200009
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,913,866
Award facts
- Opportunity
-
- NIHAI2010090 Solicitation number
- Contract value 86% obligated
-
- $1,913,866.00 Current, with exercised options
- $2,229,476.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $315,610 | |
| Exercise an Option | $329,572 | |
| Funding Only Action | $531,388 | |
| Exercise an Option | $0 | |
| Original award | $737,296 |
About this award
This is a federal contract award to SRI International, a non-profit research and development institute, by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services. The award, valued at $2,229,476.00, is for a delivery order to conduct preclinical services, including in vitro ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) studies and small animal pharmacokinetic studies, in support of the development of interventional agents for infectious diseases. This award is not associated with a set-aside program and is part of a larger NIAID program for preclinical services. SRI International has extensive experience conducting biomedical research and providing technical services to federal agencies through both contracts and grants.
Quick answers
Who was awarded contract HHSN27200009?
HHSN27200009 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 17, 2016.
How much is contract HHSN27200009 worth?
The government has obligated $1,913,866 on HHSN27200009. Its potential value, with all options, is $2,229,476.
Is contract HHSN27200009 an order under another contract?
Yes. HHSN27200009 is a delivery order under HHSN272201100022I, an indefinite delivery contract.
Was contract HHSN27200009 competed?
The extent of competition for HHSN27200009 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award